Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) prospects have taken a significant hit on the company being forced to halt ...

Fintel reports that on May 28, 2025, Leerink Partners downgraded their outlook for Boundless Bio (NasdaqGS:BOLD) from ...

Fintel reports that on May 28, 2025, Leerink Partners downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Johnson & Johnson shows strong profitability and solid value, but faces growth uncertainty, legal risks, and pricing ...

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

While UnitedHealth has suffered badly from multiple headwinds, contrarians have a case for a near-term recovery in UNH stock.

On Wednesday, Leerink Partners issued a downgrade for Boundless Bio Inc. (NASDAQ:BOLD) stock, changing its rating from Outperform to Market Perform. The firm also significantly reduced the price ...

On Monday, Leerink Partners shifted its stance on Fulcrum Therapeutics (NASDAQ:FULC), upgrading the stock from Market Perform to Outperform and setting a new price target of $12.00. The decision ...

Detailed price information for Elanco Animal Health Inc (ELAN-N) from The Globe and Mail including charting and trades.

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) on Tuesday announced an update related to RP-A501, its investigational gene therapy ...